study” said the researchers. The new study involved a larger sample size and multi-center collaboration, which strengthens the evidence supporting rectum-sparing management for patients with rectal cancer who have a complete or major clinical response to neoadjuvant therapy. This approach can help avoid unnecessary surgery and its associated risks and complications, while still providing effective treatment for patients with rectal cancer.
Source link